Irritable Bowel Syndrome Treatment Market Thumbnail Image

2020

Irritable Bowel Syndrome Treatment Market

Irritable Bowel Syndrome Treatment Market, by Type (IBS with Diarrhea (IBS-D), IBS with Constipation (IBS-C), and Mixed IBS (IBS-M), Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, and Others), and End User (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2019-2026

LS : Pharmaceuticals

  • Jan 2020

  • Pages: 250

  • Tables: 114

  • Charts: 43

Select an option
Cloud Access (28% Off) $3,456 $2,488
Business User License (28% Off) $5,769 $4,154
Enterprise License (28% Off) $10,995 $7,916
Library Membership (15% Off) $1,175 $999
Request Free Sample
Author's: Sayali Shinde | Eswara Prasad
Publish Date:
Enquire Before Buying Speak with Analyst